Cardiovascular-Kidney-Metabolic Conditions and Population Health: The Need for an Integrated Care Strategy
In brief
Integrated care programs boost guideline-directed therapy use in cardio-kidney-metabolic patients
Cardio-kidney-metabolic syndrome, a common mix of obesity, diabetes, CKD and CVD, carries high morbidity and mortality. Randomized trials show that team-based integrated care models raise the proportion of patients receiving guideline-directed treatments compared with clinician-only reminders. This suggests a scalable way to improve outcomes, costs and provider well-being, though real-world implementation remains to be tested.
- Journal
- Clinical journal of the American Society of Nephrology : CJASN (Q1)
- Published
- 6 August 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Ayodele Odutayo, Sacha Bhatia, Peter Blake, Esti Heale, Fredrika Scarth, Christopher Simpson, et al.
- PMID
- 42560777
- DOI
- 10.2215/CJN.0000001143
Why clinicians should know about it
- Picked for Critical Care and Intensive Care Medicine (top studies of the week, 9 August 2026): High-quality evidence in a top journal
- Picked for Endocrinology, Diabetes and Metabolism (top studies of the week, 9 August 2026).
- Picked for Nephrology (top studies of the week, 9 August 2026): Recent Nephrology research from a high-quartile journal
- Picked for Transplantation (top studies of the week, 9 August 2026): RCT of integrated care for cardio‑kidney‑metabolic syndrome
Abstract
Cardio-kidney-metabolic (CKM) syndrome, characterized by the combination of metabolic factors (obesity, diabetes), chronic kidney disease (CKD) or cardiovascular disease (CVD), is highly prevalent and confers a high risk of morbidity and mortality. The treatment of CKM syndrome is rapidly evolving, with multiple treatments now shown to reduce CKD progression, and incident CVD and heart failure - creating a unique opportunity to alter the natural history of CKM syndrome and improve population health. While efforts to improve the treatment for CKM syndrome have principally focused on clinician-level interventions, such as reminders or education, these strategies have had only a modest impact on population health. In contrast to clinician-level interventions, integrated care programs are collaborative healthcare teams and/or organizations delivering comprehensive person-centred care by removing barriers, supporting people throughout their healthcare journey and increasing healthcare capacity and equity. In randomized controlled trials, integrated care programs have demonstrated efficacy in increasing the use of guideline-directed treatment for people with CKM syndrome. This paper will review the evidence supporting integrated care programs as a population health strategy for CKM syndrome and propose a framework for integrated care programs specific to CKM syndrome to deliver the quadruple aim of better patient experience, improved population health, reduced healthcare costs and improved provider well-being.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.